Cartesian Therapeutics, Inc. (RNAC): Total Assets
$296.41M
As of 2025-12-31
$318.63M
As of 2026-06-30
+21.3%
3-year compound annual growth
+12.4%
5-year compound annual growth
+21.3%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $296.41M | -31.9% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $435.02M | +42.6% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $305.05M | +83.9% | 2025-03-13, Balance as of period end |
| 2022-12-31 | $165.89M | +3.8% | 2024-03-07, Balance as of period end |
| 2021-12-31 | $159.88M | -3.4% | 2023-03-02, Balance as of period end |
| 2020-12-31 | $165.44M | +66.2% | 2022-03-10, Balance as of period end |
| 2019-12-31 | $99.57M | +123.8% | 2021-03-12, Balance as of period end |
| 2018-12-31 | $44.48M | -56.0% | 2020-03-12, Balance as of period end |
| 2017-12-31 | $101.10M | +13.2% | 2019-03-15, Balance as of period end |
| 2016-12-31 | $89.30M | +108.5% | 2018-03-15, Balance as of period end |
| 2015-12-31 | $42.82M | n/a | 2017-03-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $296.41M | -31.9% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $353.77M | -26.6% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $8.36M | +21.2% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $37.66M | -3.0% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $6.34M | -22.2% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $117.81M | +50.4% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $19.07M | -13.4% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $9.98M | +4.3% |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | $530.92M | +42.0% |
Compare RNAC, UPB, XBIO, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗